Losses and impairments on loans, guarantees, unused credit facilities and loan approval – Q3 2026

Note 8 Losses and impairments on loans, guarantees, unused credit facilities and loan approval

Changes in losses and impairments under IFRS 9 on loans, guarantees, unused credit facilities and loan approvals	Calculated by model			Total calculated by model losses	Individually assessed	Total
30.09.26						GROUP
	Stage 1	Stage 2	Stage 3		Stage 3
Loss provision in opening balance	605	498	526	1,629	428	2,057
Transferred to 12-month ECL (Stage 1)	120	-108	-8	4	-4	0
Transferred to lifetime ECL – no objective evidence of loss (Stage 2)	-50	69	-18	1	-1	0
Transferred to lifetime ECL – objective evidence of loss (Stage 3) – Calculated by model	-4	-54	65	7	-7	0
Transferred to lifetime ECL – objective evidence of loss (Stage 3) – Individually assessed	-3	-8	-81	-92	92	0
Net new measurement of losses	-203	82	216	95	247	342
Newly issued or acquired financial assets	151	86	85	322	117	439
Financial assets derecognised	-172	-161	-198	-531	-136	-667
Loss provision closing balance	444	404	586	1,434	736	2,170
Loan loss provision	383	367	539	1,289	685	1,974
Provision for guarantees, unused credit facilities and loan approvals	61	37	47	145	51	196
Total loss provision	444	404	586	1,434	736	2,170
Gross lending recognised at amortised cost, allocated to different stages – opening balance	426,861	33,513	2,096	462,470	1,138	463,608
Gross lending recognised at amortised cost, allocated to different stages – closing balance	456,030	32,401	3,026	491,458	1,718	493,176
of which corporate marked	128,007	21,486	2,151	151,644	1,656	153,301
of which retail marked	328,023	10,915	875	339,813	62	339,876
Distribution corporate/retail customers
Impairment losses in opening balance
Corporate customers	457	394	407	1,258	409	1,667
Retail customers	148	104	119	371	19	390
Total impairment losses	605	498	526	1,629	428	2,057
Impairment losses closing balance
Corporate customers	319	294	437	1,050	712	1,762
Retail customers	125	110	149	384	24	408
Total impairment losses	444	404	586	1,434	736	2,170

Loss cost for the period
Changes in individual impairment for the period	437
Currency gain and other changes	0
Confirmed loss in the period with previous individual impairment	52
Confirmed loss in the period with no previous individual impairment	-40
Recoveries in previously confirmed impairments	-21
Net effect on profit/loss from individual impairments	428
Changes in losses for the period, calculated by model (Stage 1–3)	-195
Losses and impairments for the period on loans, guarantees, unused credit and loan approvals	233

	Calculated by model			Total calculated by model losses	Individually assessed	Total
	Stage 1	Stage 2	Stage 3		Stage 3
Gross lending recognised at amortised cost closing balance	456,030	32,401	3,026	491,458	1,718	493,176
Impairment loss	-383	-367	-539	-1,289	-685	-1,974
Net lending recognised at amortised cost in the balance sheet	455,647	32,034	2,487	490,169	1,033	491,202
Loans valued at fair value						20,041
Capitalised lending closing balance						511,242

ECL = Expected Credit Loss

In line with IFRS 9, the Bank classifies its loans into three stages based on the probability of default (PD) at initial recognition compared with the PD at the balance sheet date, as well as assessments against the watchlist, forbearance status, and instalments more than 30 days past due. Allocation to stage 1, 2, or 3 is therefore performed for each individual loan (or exposure). All exposures measured at amortised cost are included in the model.

Stage 1 is the starting point for financial assets covered by the general loss model, for which a provision will be made corresponding to 12-month expected losses.

Stage 2 includes assets that have experienced a significant increase in credit risk since initial recognition but for which there is no objective evidence of impairment. Exposures in Stages 1 and 2 are assessed on a portfolio basis (calculated by model).

Stage 3 of the model includes assets for which the credit risk has increased significantly since initial recognition, and where there has been objective evidence of a loss event on the balance sheet date. They are divided into loans that have been individually assessed and loans assessed at portfolio level (calculated by model).

Transfers between stages show the portion of expected credit losses in the opening balance that has migrated between the respective stages. The effect of changes in measurement methodology, as well as new calculations during the quarter, is presented under Net remeasurement of impairment losses. Impairment losses are recognised (charged against the customer’s exposure) once all collateral has been realised and it is beyond doubt that the Bank will receive no further payments on the exposure. The claim against the customer remains and continues to be monitored unless a formal debt forgiveness agreement has been concluded.

Impairments on guarantees, undrawn credit facilities, and loan commitments include off-balance sheet items and are recognised as a liability in the financial statements.

Changes in losses and impairments under IFRS 9 on loans, guarantees, unused credit facilities and loan approvals	Calculated by model			Total calculated by model losses	Individually assessed	Total
30.09.25						GROUP
	Stage 1	Stage 2	Stage 3		Stage 3
Loss provision in opening balance	262	351	186	799	250	1,049
Transferred to 12-month ECL (Stage 1)	68	-56	-5	7	-7	0
Transferred to lifetime ECL – no objective evidence of loss (Stage 2)	-18	63	-45	-1	1	0
Transferred to lifetime ECL – objective evidence of loss (Stage 3) – Calculated by model	-3	-47	50	0	0	0
Transferred to lifetime ECL – objective evidence of loss (Stage 3) – Individually assessed	-1	-5	-6	-12	12	0
Net new measurement of losses	-45	83	78	116	76	192
Newly issued or acquired financial assets	176	130	34	340	40	380
Financial assets derecognised	-71	-147	-70	-288	-138	-426
Addition through merger	118	243	295	656	199	855
Loss provision closing balance	486	614	518	1,617	433	2,050
Loan loss provision	407	558	417	1,381	378	1,760
Provision for guarantees, unused credit facilities and loan approvals	79	56	101	236	55	291
Total loss provision	486	614	518	1,617	433	2,050
Gross lending recognised at amortised cost, allocated to different stages opening balance	238,884	20,333	999	260,216	393	260,609
Gross lending recognised at amortised cost, allocated to different stages closing balance	414,907	31,331	2,096	448,334	1,055	449,389
Distribution corporate/retail customers
Impairment losses in opening balance
Corporate customers	213	262	126	600	245	846
Retail customers	49	90	61	199	5	203
Total impairment losses	262	351	186	799	250	1,049
Impairment losses closing balance
Corporate customers	316	422	365	1,102	399	1,501
Retail customers	170	192	153	515	35	549
Total impairment losses	486	614	518	1,617	433	2,050

Loss cost for the period
Changes in individual impairment for the period	-16
Currency gain and other changes	0
Confirmed loss in the period with previous individual impairment	79
Confirmed loss in the period with no previous individual impairment	86
Recoveries in previously confirmed impairments	-11
Net effect on profit/loss from individual impairments	138
Changes in losses for the period, calculated by model (Stage 1–3)	125
Losses and impairments for the period on loans, guarantees, unused credit and loan approvals	263

	Calculated by model			Total calculated by model losses	Individually assessed	Total
	Stage 1	Stage 2	Stage 3		Stage 3
Gross lending recognised at amortised cost closing balance	414,907	31,331	2,096	448,334	1,055	449,389
Impairment loss	-407	-558	-417	-1,381	-378	-1,760
Net lending recognised at amortised cost in the balance sheet	414,500	30,772	1,680	446,952	677	447,629
Loans valued at fair value						24,827
Capitalised lending closing balance						472,456

Changes in losses and impairments under IFRS 9 on loans, guarantees, unused credit facilities and loan approvals	Calculated by model			Total calculated by model losses	Individually assessed	Total
30.09.26						PARENT BANK
	Stage 1	Stage 2	Stage 3		Stage 3
Loss provision in opening balance	484	421	427	1,332	298	1,630
Transferred to 12-month ECL (Stage 1)	82	-77	-5	0	0	0
Transferred to lifetime ECL – no objective evidence of loss (Stage 2)	-46	54	-8	0	0	0
Transferred to lifetime ECL – objective evidence of loss (Stage 3) – Calculated by model	-4	-50	58	5	-5	0
Transferred to lifetime ECL – objective evidence of loss (Stage 3) – Individually assessed	-2	-5	-78	-85	85	0
Net new measurement of losses	-151	60	171	80	197	278
Newly issued or acquired financial assets	115	70	77	262	114	376
Financial assets derecognised	-149	-146	-176	-470	-115	-585
Loss provision closing balance	330	327	467	1,124	574	1,698
Loan loss provision	271	290	420	982	523	1,505
Provision for guarantees, unused credit facilities and loan approvals	59	37	47	143	51	193
Total loss provision	330	327	467	1,124	574	1,698

Loss cost for the period
Changes in individual impairment for the period	276
Currency gain and other changes	0
Confirmed loss in the period with previous individual impairment	52
Confirmed loss in the period with no previous individual impairment	46
Recoveries in previously confirmed impairment	-19
Net effect on profit/loss from individual impairments	355
Changes in losses for the period, calculated by model (Stage 1–3)	-208
Losses and impairments for the period on loans, guarantees, unused credit and loan approvals	147

	Calculated by model			Total calculated by model losses	Individually assessed	Total
	Stage 1	Stage 2	Stage 3		Stage 3
Gross lending recognised at amortised cost or fair value through other comprehensive income closing balance	202,275	24,167	2,231	228,674	1,038	229,712
Impairment loss	-271	-290	-420	-982	-523	-1,505
Net lending	202,004	23,877	1,811	227,692	515	228,207
Loans valued at fair value						10,108
Capitalised lending closing balance						238,315

Changes in losses and impairments under IFRS 9 on loans, guarantees, unused credit facilities and loan approvals	Calculated by model			Total calculated by model losses	Individually assessed	Total
30.09.25						PARENT BANK
	Stage 1	Stage 2	Stage 3		Stage 3
Loss provision in opening balance	233	299	161	693	250	943
Transferred to 12-month ECL (Stage 1)	53	-44	-3	6	-6	0
Transferred to lifetime ECL – no objective evidence of loss (Stage 2)	-17	56	-39	0	0	0
Transferred to lifetime ECL – objective evidence of loss (Stage 3) – Calculated by model	-2	-43	45	0	0	0
Transferred to lifetime ECL – objective evidence of loss (Stage 3) – Individually assessed	-1	0	-2	-4	4	0
Net new measurement of losses	-27	66	48	87	74	160
Newly issued or acquired financial assets	147	115	19	282	26	308
Financial assets derecognised	-63	-135	-54	-253	-113	-366
Addition through merger	73	199	253	525	66	592
Loss provision closing balance	395	512	428	1,335	302	1,637
Loan loss provision	319	456	328	1,103	247	1,350
Provision for guarantees, unused credit facilities and loan approvals	77	56	100	232	55	287
Total loss provision	395	512	428	1,335	302	1,637

Loss cost for the period
Changes in individual impairment for the period	-14
Currency gain and other changes	0
Confirmed loss in the period with previous individual impairment	79
Confirmed loss in the period with no previous individual impairment	55
Recoveries in previously confirmed impairments	-7
Net effect on profit/loss from individual impairments	112
Changes in losses for the period, calculated by model (Stage 1–3)	80
Losses and impairments for the period on loans, guarantees, unused credit and loan approvals	192

	Calculated by model			Total calculated by model losses	Individually assessed	Total
	Stage 1	Stage 2	Stage 3		Stage 3
Gross lending recognised at amortised cost or fair value through other comprehensive income closing balance	193,865	22,295	1,520	217,680	582	218,262
Impairment loss	-319	-456	-328	-1,103	-247	-1,350
Net lending recognised at amortised cost in the balance sheet	193,546	21,839	1,193	216,577	335	216,912
Loans valued at fair value						12,792
Capitalised lending closing balance						229,704

Q3 2026Unaudited

Note 8 Losses and impairments on loans, guarantees, unused credit facilities and loan approval